Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Chronic Pain

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Chronic Pain in 1 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.

Research Excerpts

ExcerptRelevanceReference
"In the primed paw AMP hyperalgesia was dependent on conversion to adenosine, being prevented by ecto-5'nucleotidase inhibitor α,β-methyleneadenosine 5'-diphosphate sodium salt and A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine."1.46Regulation of Expression of Hyperalgesic Priming by Estrogen Receptor α in the Rat. ( Araldi, D; Ferrari, LF; Levine, JD, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferrari, LF1
Araldi, D1
Levine, JD1

Other Studies

1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Chronic Pain

ArticleYear
Regulation of Expression of Hyperalgesic Priming by Estrogen Receptor α in the Rat.
    The journal of pain, 2017, Volume: 18, Issue:5

    Topics: 5'-Nucleotidase; Adenosine; Adenosine A1 Receptor Antagonists; Adenosine Monophosphate; Animals; Chr

2017
chemdatabank.com